🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Featuring Nadine Mallak, MD 😎 ☢️ OHSU Radiology OHSU Knight Cancer Institute

Nadine Mallak, MD will be speaking on NET imaging at our 2023 LACNETS Annual Conference on June 17th. Virtual & free to all! Register here: lacnets.org/2023conference

Thank you very much Dr. Julie Hallet and Dr. Singh for having me, and for organising this wonderful meeting NANETS

Pancreas, carcinoid🫀, 🫁 & small bowel NETs tumor board reviews to close NANETS Toronto regional conference - can’t repeats it enough, multidisciplinary management is 🔑. Consider presenting #NETs to NET-focused tumor boards. Callisia Clarke MD Nadine Mallak, MD Alexandra Gangi, MD Aman Chauhan

Julie Hallet gets the 👑 — she set the bar high! Fantastic host and organizer! Had a blast nerding out on #neuroendocrine and learning about hockey. Look forward to returning to 🇨🇦 for NANETS Symposium in October!

1. For the fourth SNMMI Correlative Imaging Council social media case, Nadine Mallak, MD from OHSU Radiology presents a case focused prostate cancer mimics on PSMA PET. She also provides a wonderful review of common pitfalls on PSMA PET. Please watch at: bit.ly/3J1SP6Y

Congrats Dr. Graham! I’m so grateful for the mentorship, sponsorship, and continued support! Amazing person, doctor, and scientist who has given so much to our field! SNMMI #mentorship #gratitude

Now that #SNMMI2023 is done, check out the four SNMMI Correlative Imaging Council cases: 1) Lisa Bodei, MD, PhD on PSMA RLT: bit.ly/3Bw5kDm 2) Drs. Cho and Larson on sarcoid: bit.ly/45srDYw 3) Dr. Jha on para/pheo: bit.ly/3OJr6eH 4) Nadine Mallak, MD on PSMA: bit.ly/3J1SP6Y

Just a week to go until this month's NETchatter. Please DM for the link to join us! NANETS @LACNETS NET Research Foundation Pheo Para Alliance CarcinoidCancer CCF NCAN NET Cancer Day Healing NET #zebrastrong #NeuroendocrineTumour #Nets #CancerSupport #NeuroendocrineCancer #LetsTalkAboutNet

Quick reminder that it's NETChatter on Thursday 27th July. We hope that you can join us. DM for the Zoom link.

💪 Fighting #NET (neuroendocrine tumors) with patients every step of the way! Thank you for inviting me to share what IR/IOs can offer to these patients. #NETchatter. NET CANCER FOUNDATION Nadine Mallak, MD OHSU Knight Cancer Institute Society of Interventional Radiology

1) For the 5th SNMMI Correlative Imaging Council social media case, Courtney Lawhn Heath from UCSF presents a case FES PET which highlights some of the important keys in using FES in patients with breast cancer. Please watch at: bit.ly/45zn6ml.

Looking for some guidance on monitoring and surveillance of patients with GEP-NETs during and following radioligand therapy (RLT)...? If so, this review may be of interest to you. That said, we need to generate more info as our RLT experience expands. mdpi.com/2072-6694/15/1…

Caffi’s RSNA prize highlights the importance of medical physics, dosimetry, and research in advancing theranostics, with a goal of precision oncology to improve patient outcomes. OHSU’s MIT section is an emerging leader in this field. Learn more: rsna.org/annual-meeting…

Congrats Caffi Meyer the trainee research prize. Very well deserved. Great work, and great presentation! OHSU Radiology #RSNA2023

NANETS UKINETS NETwerk Thor Halfdanarson Thomas Hope Nadine Mallak, MD David Chan FDG-PET consider when ▪️CT lesions but faint SSTR+ ▫️NET G3 for surgery or loc-reg treatment ▪️NEC for baseline before treatment If prior G1-2 NET develops FDG+➡️re-biopsy In mixed tumor, if residual SSTR+ after FDG+ disease responded to other Rx➡️consider PRRT Need⬆️data &

☢️ Exciting news! Check out our new article. Go-to resource for understanding the nuts and bolts of #Theranostics. Perfect for trainees, breaks down the physics and clinical applications in a fun, easy to digest, manner #MedEd #nuclearMedicine #medicalPhysics OHSU Radiology

New AJR Accepted Manuscripts: "Inpatient FDG PET/CT" 🟡Point: By Drs Szidonya & Nadine Mallak, MD OHSU Radiology 🟡Counterpoint: By Drs Eric Dietsche, MD & Scaringi The Warren Alpert Medical School ajronline.org/doi/10.2214/AJ… ajronline.org/doi/10.2214/AJ…

🚨PRRT 1st line benefits in G2-3 advanced GEP-NETs - NETTER2 #GI24 ⬆️PFS by >12m median (vs SSA)👉🏻supports PRRT 1st line in G2-3 💥Unprecedented response rate: 43%👉🏻time for neoadj trial? 🤷🏻‍♀️G2-3 not bad with SSA: median PFS 8m & 9% ORR 👏🏻to team & PI Dr Singh Sunnybrook Health Sciences Centre!

Registration is open! I'm hosting another fantastic webinar on the benefits of peer coaching, cosponsored by Intelerad, RadEqual, and AAWR. intelerad.zoom.us/webinar/regist…